Autism is a life-long disability that as of today neither have a biological- based clinical diagnostics not an effective pharmacological treatment.
Point6 Bio is a computational biology company focused on capturing multi-omics molecular insights from the proteome including from subject’s gut microbiome, to identify biomarker signatures, which will eventually affect treatment decision and new drug targets identification in Autism.
CEO: Dr. Neta Barashi